Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyCellularComponent	Golgi cis cisterna	GOLGA8S GOLGA8T GOLGA8R GOLGA8K	7.48e-06	33	80	4	GO:0000137
GeneOntologyCellularComponent	Golgi cisterna membrane	GOLGA8S GOLGA8T GOLGA8R GOLGA8K CSGALNACT1	3.04e-05	94	80	5	GO:0032580
GeneOntologyCellularComponent	Golgi cisterna	GOLGA8S GOLGA8T GOLGA8R GOLGA8K CSGALNACT1	1.70e-04	135	80	5	GO:0031985
GeneOntologyCellularComponent	cis-Golgi network	GOLGA8S GOLGA8T GOLGA8R GOLGA8K	3.18e-04	85	80	4	GO:0005801
GeneOntologyCellularComponent	Golgi stack	GOLGA8S GOLGA8T GOLGA8R GOLGA8K CSGALNACT1	5.06e-04	171	80	5	GO:0005795
GeneOntologyCellularComponent	spectrin	SPTAN1 SPTB	5.12e-04	9	80	2	GO:0008091
GeneOntologyCellularComponent	postsynaptic density, intracellular component	AKAP5 DLG3 DICER1	8.76e-04	49	80	3	GO:0099092
GeneOntologyCellularComponent	glutamatergic synapse	USP14 NEO1 AKAP5 CELSR3 SPTAN1 SPTB DAPK1 DLG3 GPC6 DICER1	1.09e-03	817	80	10	GO:0098978
GeneOntologyCellularComponent	postsynaptic specialization, intracellular component	AKAP5 DLG3 DICER1	1.29e-03	56	80	3	GO:0099091
Domain	Neogenin_C	NEO1 DCC	1.72e-05	2	78	2	IPR010560
Domain	Neogenin_C	NEO1 DCC	1.72e-05	2	78	2	PF06583
Domain	-	KLHL8 CCIN KLHL31	1.91e-04	27	78	3	2.130.10.80
Domain	Gal_Oxidase_b-propeller	KLHL8 CCIN KLHL31	3.82e-04	34	78	3	IPR015916
Domain	Ubiquitin-rel_dom	USP14 UBQLNL PTPN14 TLN1 PLCE1	1.04e-03	184	78	5	IPR029071
Domain	Kelch	KLHL8 CCIN KLHL31	1.83e-03	58	78	3	SM00612
Domain	Gal_Oxase/kelch_b-propeller	KLHL8 CCIN KLHL31	1.93e-03	59	78	3	IPR011043
Domain	BACK	KLHL8 CCIN KLHL31	2.02e-03	60	78	3	SM00875
Domain	BACK	KLHL8 CCIN KLHL31	2.12e-03	61	78	3	PF07707
Domain	BACK	KLHL8 CCIN KLHL31	2.12e-03	61	78	3	IPR011705
Domain	Kelch_1	KLHL8 CCIN KLHL31	3.14e-03	70	78	3	PF01344
Domain	Kelch_1	KLHL8 CCIN KLHL31	3.14e-03	70	78	3	IPR006652
Domain	Spectrin	SPTAN1 SPTB	4.12e-03	23	78	2	PF00435
Domain	FERM_CS	PTPN14 TLN1	4.48e-03	24	78	2	IPR019747
Domain	Spectrin_repeat	SPTAN1 SPTB	6.50e-03	29	78	2	IPR002017
Domain	JMJC	KDM5A HIF1AN	7.87e-03	32	78	2	PS51184
Domain	Spectrin/alpha-actinin	SPTAN1 SPTB	7.87e-03	32	78	2	IPR018159
Domain	JmjC_dom	KDM5A HIF1AN	7.87e-03	32	78	2	IPR003347
Domain	SPEC	SPTAN1 SPTB	7.87e-03	32	78	2	SM00150
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	USP31 LSR NEO1 AKAP5 PTPN14 IMPDH2 SPTAN1 TLN1 UBR4 TOMM34 SAMM50 HMOX2 RABL3 DICER1 NSDHL	1.55e-06	1487	81	15	33957083
Pubmed	Ubiquitin-specific peptidase 14 maintains estrogen receptor α stability via its deubiquitination activity in endometrial cancer.	USP14 ESR1	5.36e-06	2	81	2	36423684
Pubmed	Variations in both α-spectrin (SPTA1) and β-spectrin ( SPTB ) in a neonate with prolonged jaundice in a family where nine individuals had hereditary elliptocytosis.	SPTAN1 SPTB	5.36e-06	2	81	2	24193021
Pubmed	No association of DAPK1 and ABCA2 SNPs on chromosome 9 with Alzheimer's disease.	ABCA2 DAPK1	5.36e-06	2	81	2	18336955
Pubmed	17β-Estradiol sensitizes ovarian surface epithelium to transformation by suppressing Disabled-2 expression.	ESR1 DAB2	5.36e-06	2	81	2	29196616
Pubmed	Neogenin regulates neuronal survival through DAP kinase.	NEO1 DAPK1	5.36e-06	2	81	2	18583991
Pubmed	Selective depletion of tumour suppressors Deleted in Colorectal Cancer (DCC) and neogenin by environmental and endogenous serine proteases: linking diet and cancer.	NEO1 DCC	5.36e-06	2	81	2	27716118
Pubmed	Interactions of the alpha-spectrin N-terminal region with beta-spectrin. Implications for the spectrin tetramerization reaction.	SPTAN1 SPTB	5.36e-06	2	81	2	9890967
Pubmed	Impaired OTUD7A-dependent Ankyrin regulation mediates neuronal dysfunction in mouse and human models of the 15q13.3 microdeletion syndrome.	SPTAN1 SPTB DLG3 TNKS1BP1 FNBP1L DCC	6.98e-06	197	81	6	36604605
Pubmed	Comparative proximity biotinylation implicates the small GTPase RAB18 in sterol mobilization and biosynthesis.	USP14 SPTAN1 TLN1 DAB2 TNKS1BP1 HMOX2 RABL3 ZYX NSDHL	7.13e-06	568	81	9	37774976
Pubmed	The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2.	MAG LSR NEO1 AKAP5 PTPN14 DAPK1 DLG3 HMOX2 RABL3	7.23e-06	569	81	9	30639242
Pubmed	Organization of focal adhesion plaques is disrupted by action of the HIV-1 protease.	SPTAN1 TLN1 SPTB	9.68e-06	18	81	3	12119179
Pubmed	miR-191/DAB2 axis regulates the tumorigenicity of estrogen receptor-positive breast cancer.	ESR1 DAB2	1.60e-05	3	81	2	29247596
Pubmed	Differential regulation of myosin X movements by its cargos, DCC and neogenin.	NEO1 DCC	1.60e-05	3	81	2	22349703
Pubmed	Mapping the binding sites of human erythrocyte ankyrin for the anion exchanger and spectrin.	SPTAN1 SPTB	1.60e-05	3	81	2	2141335
Pubmed	The spatial and temporal expression patterns of netrin receptors, DCC and neogenin, in the developing mouse retina.	NEO1 DCC	1.60e-05	3	81	2	10843775
Pubmed	The complete amino acid sequence for brain beta spectrin (beta fodrin): relationship to globin sequences.	SPTAN1 SPTB	1.60e-05	3	81	2	8479293
Pubmed	Developmental expression of brain beta-spectrin isoform messenger RNAs.	SPTAN1 SPTB	1.60e-05	3	81	2	1467942
Pubmed	Expanding the Interactome of TES by Exploiting TES Modules with Different Subcellular Localizations.	TKT SPTAN1 TLN1 UBR4 TNKS1BP1 ZYX	1.90e-05	235	81	6	28378594
Pubmed	C5orf51 is a component of the MON1-CCZ1 complex and controls RAB7A localization and stability during mitophagy.	NPC1 TDRKH NEO1 ZFYVE16 TENM1 SAMM50 HMOX2 RABL3	2.34e-05	504	81	8	34432599
Pubmed	The expression patterns of guidance receptors, DCC and Neogenin, are spatially and temporally distinct throughout mouse embryogenesis.	NEO1 DCC	3.20e-05	4	81	2	9441666
Pubmed	MicroRNA-135b regulates ERα, AR and HIF1AN and affects breast and prostate cancer cell growth.	ESR1 HIF1AN	3.20e-05	4	81	2	25907805
Pubmed	Focal adhesion kinase in netrin-1 signaling.	NEO1 DCC	3.20e-05	4	81	2	15494733
Pubmed	Myosin X regulates netrin receptors and functions in axonal path-finding.	NEO1 DCC	3.20e-05	4	81	2	17237772
Pubmed	Different levels of the Tripartite motif protein, Anomalies in sensory axon patterning (Asap), regulate distinct axonal projections of Drosophila sensory neurons.	NEO1 DCC	3.20e-05	4	81	2	22084112
Pubmed	Genetic variations in the Hippo signaling pathway and breast cancer risk in African American women in the AMBER Consortium.	PTPN14 ESR1	3.20e-05	4	81	2	27485598
Pubmed	MicroRNAs link estrogen receptor alpha status and Dicer levels in breast cancer.	ESR1 DICER1	3.20e-05	4	81	2	21761362
Pubmed	Identification of the spectrin subunit and domains required for formation of spectrin/adducin/actin complexes.	SPTAN1 SPTB	3.20e-05	4	81	2	8663089
Pubmed	The spectrin-based membrane skeleton stabilizes mouse megakaryocyte membrane systems and is essential for proplatelet and platelet formation.	SPTAN1 SPTB	3.20e-05	4	81	2	21566095
Pubmed	Remarkable homology among the internal repeats of erythroid and nonerythroid spectrin.	SPTAN1 SPTB	3.20e-05	4	81	2	3862089
Pubmed	Phosphatidylinositol transfer protein-alpha in netrin-1-induced PLC signalling and neurite outgrowth.	NEO1 DCC	3.20e-05	4	81	2	16244667
Pubmed	Plasma membrane-cytoskeleton-endoplasmic reticulum complexes in neurons and astrocytes.	SPTAN1 SPTB	3.20e-05	4	81	2	14593108
Pubmed	Motor axon guidance of the mammalian trochlear and phrenic nerves: dependence on the netrin receptor Unc5c and modifier loci.	NEO1 DCC	3.20e-05	4	81	2	16723533
Pubmed	Spectrin alpha II and beta II isoforms interact with high affinity at the tetramerization site.	SPTAN1 SPTB	3.20e-05	4	81	2	12820899
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	KDM5A TKT SPTAN1 CD2BP2 TLN1 FNBP1L DICER1 ZYX EXOSC4	4.79e-05	724	81	9	36232890
Pubmed	Netrin 1 acts as an attractive or as a repulsive cue for distinct migrating neurons during the development of the cerebellar system.	NEO1 DCC	5.33e-05	5	81	2	10704383
Pubmed	Inhibitory actions of genistein in human breast cancer (MCF-7) cells.	ESR1 DAB2	5.33e-05	5	81	2	12853125
Pubmed	Developmentally regulated expression of Netrin-1 and -3 in the embryonic mouse molar tooth germ.	NEO1 DCC	5.33e-05	5	81	2	12889066
Pubmed	Ventricular expression of tbx5 inhibits normal heart chamber development.	MYL4 NKX2-5	5.33e-05	5	81	2	10864469
Pubmed	An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.	PTPN14 GYS1 CD2BP2 BUB1 TNKS1BP1 SAMM50 RABL3 DICER1 HIF1AN ZYX EXOSC4 NSDHL	5.39e-05	1321	81	12	27173435
Pubmed	GWAS for discovery and replication of genetic loci associated with sudden cardiac arrest in patients with coronary artery disease.	ESR1 RSPH6A PLCE1	6.31e-05	33	81	3	21658281
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	ESR1 ZMIZ2 TLN1 UBR4 BUB1 DAB2 NKX2-5	6.66e-05	430	81	7	35044719
Pubmed	Gene-environment interactions and obesity traits among postmenopausal African-American and Hispanic women in the Women's Health Initiative SHARe Study.	SLC28A3 DCC DICER1	7.55e-05	35	81	3	23192594
Pubmed	Netrin-1 promotes thalamic axon growth and is required for proper development of the thalamocortical projection.	NEO1 DCC	7.99e-05	6	81	2	10908620
Pubmed	Simultaneous binding of Guidance Cues NET1 and RGM blocks extracellular NEO1 signaling.	NEO1 DCC	7.99e-05	6	81	2	33740419
Pubmed	Retinoblastoma-binding protein 2 (Rbp2) potentiates nuclear hormone receptor-mediated transcription.	KDM5A ESR1	7.99e-05	6	81	2	11358960
Pubmed	Neural migration. Structures of netrin-1 bound to two receptors provide insight into its axon guidance mechanism.	NEO1 DCC	7.99e-05	6	81	2	24876346
Pubmed	Genetic analysis of DSCAM's role as a Netrin-1 receptor in vertebrates.	NEO1 DCC	7.99e-05	6	81	2	22238077
Pubmed	Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis.	USP14 ABCA2 TKT SPTAN1 TLN1 UBR4 DAPK1 SAMM50 NSDHL	1.10e-04	807	81	9	30575818
Pubmed	Defects in neural guidepost structures and failure to remove leptomeningeal cells from the septal midline behind the interhemispheric fusion defects in Netrin1 deficient mice.	NEO1 DCC	1.12e-04	7	81	2	26397040
Pubmed	Chromosomal location of three spectrin genes: relationship to the inherited hemolytic anemias of mouse and man.	SPTAN1 SPTB	1.12e-04	7	81	2	3186715
Pubmed	Cloning of three mouse Unc5 genes and their expression patterns at mid-gestation.	NEO1 DCC	1.12e-04	7	81	2	12351186
Pubmed	Netrins and DCC in the guidance of migrating neural crest-derived cells in the developing bowel and pancreas.	NEO1 DCC	1.12e-04	7	81	2	12798294
Pubmed	Rb/E2F regulates expression of neogenin during neuronal migration.	NEO1 DCC	1.12e-04	7	81	2	21059867
Pubmed	A protein interaction landscape of breast cancer.	PTPN14 IMPDH2 LOXL2 ESR1 TLN1 UBR4 DAB2 SAMM50	1.17e-04	634	81	8	34591612
Pubmed	Immunoaffinity profiling of tyrosine phosphorylation in cancer cells.	IMPDH2 ZFYVE16 TKT TLN1 DAB2 DICER1	1.18e-04	327	81	6	15592455
Pubmed	A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.	USP14 IMPDH2 SPTAN1 TLN1 UBR4 DAB2 TNKS1BP1 SAMM50 HMOX2 SSBP3 RABL3 DICER1	1.22e-04	1440	81	12	30833792
Pubmed	Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking.	IMPDH2 SPTAN1 GYS1 TLN1 UBR4 DAB2	1.29e-04	332	81	6	32786267
Pubmed	The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1.	AKAP5 UBR4 TNKS1BP1 DICER1 HIF1AN	1.41e-04	212	81	5	33853758
Pubmed	Floor plate and netrin-1 are involved in the migration and survival of inferior olivary neurons.	NEO1 DCC	1.49e-04	8	81	2	10341242
Pubmed	The conformational state of Tes regulates its zyxin-dependent recruitment to focal adhesions.	TLN1 ZYX	1.49e-04	8	81	2	12695497
Pubmed	BioID Performed on Golgi Enriched Fractions Identify C10orf76 as a GBF1 Binding Protein Essential for Golgi Maintenance and Secretion.	USP14 IMPDH2 TLN1 DAB2 ZYX	1.54e-04	216	81	5	31519766
Pubmed	A comprehensive SARS-CoV-2-human protein-protein interactome reveals COVID-19 pathobiology and potential host therapeutic targets.	IMPDH2 ZMIZ2 SPTAN1 UBR4 SAMM50 HMOX2 RABL3	1.75e-04	503	81	7	36217030
Pubmed	RASSF1A, APC, ESR1, ABCB1 and HOXC9, but not p16INK4A, DAPK1, PTEN and MT1G genes were frequently methylated in the stage I non-small cell lung cancer in China.	ESR1 DAPK1	1.91e-04	9	81	2	19506903
Pubmed	N-Terminomics for the Identification of In Vitro Substrates and Cleavage Site Specificity of the SARS-CoV-2 Main Protease.	TKT SPTAN1 CD2BP2 TLN1 SPTB TNKS1BP1	1.99e-04	360	81	6	33111431
Pubmed	Systematically defining selective autophagy receptor-specific cargo using autophagosome content profiling.	NPC1 IMPDH2 ZFYVE16 LOXL2 SPTAN1 GYS1 UBR4 TNKS1BP1 KLHL8 ZYX NSDHL	2.06e-04	1297	81	11	33545068
Pubmed	Cell organization, growth, and neural and cardiac development require αII-spectrin.	SPTAN1 SPTB	2.38e-04	10	81	2	22159418
Pubmed	Proteomic analysis of integrin-associated complexes identifies RCC2 as a dual regulator of Rac1 and Arf6.	MYL4 IMPDH2 TKT TLN1 UBR4 DAB2 TOMM34 ZYX	2.44e-04	707	81	8	19738201
Pubmed	The Activation-Induced Assembly of an RNA/Protein Interactome Centered on the Splicing Factor U2AF2 Regulates Gene Expression in Human CD4 T Cells.	IMPDH2 TKT SPTAN1 TLN1 ZYX	2.46e-04	239	81	5	26641092
Pubmed	Host E3 ligase HUWE1 attenuates the proapoptotic activity of the MERS-CoV accessory protein ORF3 by promoting its ubiquitin-dependent degradation.	USP14 IMPDH2 TKT CD2BP2 UBR4 TOMM34 NSDHL	2.52e-04	534	81	7	35032548
Pubmed	Optimized fragmentation schemes and data analysis strategies for proteome-wide cross-link identification.	NPC1 USP14 IMPDH2 TKT SPTAN1 TLN1 TNKS1BP1	2.64e-04	538	81	7	28524877
Pubmed	Brain proteins interacting with the tetramerization region of non-erythroid alpha spectrin.	SPTAN1 SPTB	2.91e-04	11	81	2	17607528
Pubmed	Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C.	MYL4 NKX2-5	2.91e-04	11	81	2	9162005
Pubmed	Chromosomal locations of genes encoding 2',3' cyclic nucleotide 3'-phosphodiesterase and glial fibrillary acidic protein in the mouse.	MYL4 B4GALNT2	2.91e-04	11	81	2	2903254
Pubmed	The combinatorial activities of Nkx2.5 and dHAND are essential for cardiac ventricle formation.	MYL4 NKX2-5	2.91e-04	11	81	2	11784028
Pubmed	Novel role for Netrins in regulating epithelial behavior during lung branching morphogenesis.	NEO1 DCC	2.91e-04	11	81	2	15186747
Pubmed	Analysis of Netrin 1 receptors during inner ear development.	NEO1 DCC	2.91e-04	11	81	2	17616930
Pubmed	miRNA-processing enzyme Dicer is necessary for cardiac outflow tract alignment and chamber septation.	NKX2-5 DICER1	2.91e-04	11	81	2	20018673
Pubmed	Netrin-1 Confines Rhombic Lip-Derived Neurons to the CNS.	NEO1 DCC	2.91e-04	11	81	2	29444422
Pubmed	LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling.	NPC1 USP14 LSR IMPDH2 TLN1 UBR4 SAMM50 HMOX2 RABL3	3.45e-04	942	81	9	31073040
Pubmed	Integrin beta cytoplasmic domain interactions with phosphotyrosine-binding domains: a structural prototype for diversity in integrin signaling.	TLN1 DAB2	3.48e-04	12	81	2	12606711
Pubmed	CHF1/Hey2 plays a pivotal role in left ventricular maturation through suppression of ectopic atrial gene expression.	MYL4 NKX2-5	3.48e-04	12	81	2	17332425
Pubmed	Transcription factors, cAMP-responsive element modulator (CREM) and Tisp40, act in concert in postmeiotic transcriptional regulation.	BUB1 DAPK1	3.48e-04	12	81	2	16595651
Pubmed	E-cadherin interactome complexity and robustness resolved by quantitative proteomics.	LSR ZFYVE16 SPTAN1 TLN1 TNKS1BP1 FNBP1L ZYX	3.54e-04	565	81	7	25468996
Pubmed	Defining the membrane proteome of NK cells.	NPC1 ABCA2 IMPDH2 GYS1 UBR4 BUB1 TOMM34 ASPHD2 HMOX2 ADCY3	3.80e-04	1168	81	10	19946888
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	USP31 ZFYVE16 TLN1 DLG3 ADCY3 PLCE1	3.84e-04	407	81	6	12693553
Pubmed	Complete Loss of Netrin-1 Results in Embryonic Lethality and Severe Axon Guidance Defects without Increased Neural Cell Death.	NEO1 DCC	4.11e-04	13	81	2	26257176
Pubmed	alphaII-betaV spectrin bridges the plasma membrane and cortical lattice in the lateral wall of the auditory outer hair cells.	SPTAN1 SPTB	4.11e-04	13	81	2	18796539
Pubmed	Myogenic and morphogenetic defects in the heart tubes of murine embryos lacking the homeo box gene Nkx2-5.	MYL4 NKX2-5	4.11e-04	13	81	2	7628699
Pubmed	Extensive molecular differences between anterior- and posterior-half-sclerotomes underlie somite polarity and spinal nerve segmentation.	DCC GPC6 ZC3H6	4.17e-04	62	81	3	19463158
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	ZFYVE16 KDM5A ZMIZ2 UBR4 BUB1 TNKS1BP1	4.42e-04	418	81	6	34709266
Pubmed	Isolation and characterization of bone marrow-derived mesenchymal progenitor cells with myogenic and neuronal properties.	MYL4 NKX2-5	4.79e-04	14	81	2	17289022
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	AKAP5 KDM5A TTC16 TKT SPTAN1 UBR4 TENM1 DLG3 FNBP1L HMOX2 DCC	5.06e-04	1442	81	11	35575683
Pubmed	Differentially expressed genes in the testicular tissues of adenylyl cyclase 3 knockout mice.	DCC ADCY3	5.52e-04	15	81	2	27864010
Pubmed	Phenotypic analysis of mice completely lacking netrin 1.	NEO1 DCC	5.52e-04	15	81	2	26395479
Pubmed	Prox1 maintains muscle structure and growth in the developing heart.	NKX2-5 ZYX	5.52e-04	15	81	2	19091769
Pubmed	Novel genetic loci identified for the pathophysiology of childhood obesity in the Hispanic population.	ESR1 SPTB SLC28A3 DCC GPC6 RABL3 PKHD1L1 KLHL31	6.21e-04	814	81	8	23251661
Pubmed	NOVA regulates Dcc alternative splicing during neuronal migration and axon guidance in the spinal cord.	NEO1 DCC	6.29e-04	16	81	2	27223328
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	TDRKH LSR IMPDH2 KDM5A ESR1 TLN1 DLG3 SSBP3 RABL3 DICER1 EXOSC4	6.90e-04	1497	81	11	31527615
Pubmed	Analysis of Expression Pattern and Genetic Deletion of Netrin5 in the Developing Mouse.	NEO1 DCC	7.12e-04	17	81	2	26858598
GeneFamily	EF-hand domain containing\|Spectrins	SPTAN1 SPTB	1.82e-04	7	54	2	1113
GeneFamily	Beta 4-glycosyltransferases	B4GALNT2 CSGALNACT1	1.16e-03	17	54	2	425
ToppCell	droplet-Lung-immune-endo-depleted-3m-Myeloid-Alveolar_Macrophage\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NPC1 MAG LSR AKAP5 DAB2 DAPK1 ADCY3	4.77e-08	185	81	7	775b72319ef6acffd2c9a74293b9c1bccea33f42
ToppCell	droplet-Lung-immune-endo-depleted-3m-Myeloid-alveolar_macrophage\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NPC1 LSR AKAP5 DAB2 DAPK1 ADCY3	1.12e-06	185	81	6	afbb88325e4a81c15ac1d0a004e3e1f4ba2ee87b
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	DAPK1 DCC GPC6 CSGALNACT1 TFPI PLCE1	1.48e-06	194	81	6	5f5f0cdeacd5e1b28717d78dabdb9eb95f661e36
ToppCell	primary_visual_cortex-Neuronal-glutamatergic_neuron-NP-L5_NP_VISp_Trhr_Met\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	ISLR2 MYL4 LOXL2 DCC GPC6	6.83e-06	145	81	5	8abbc781f5f69f039617c29a5589d7b6950c2c40
ToppCell	PBMC-Mild-Hematopoietic-Platelet-Platelet-plt_0\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	SPTB DAB2 FNBP1L PKHD1L1 TFPI	1.28e-05	165	81	5	6799a6580c667738995cceb31cbf1c7fbdc4ff84
ToppCell	PBMC-Mild-Hematopoietic-Platelet-Platelet-plt_0\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SPTB DAB2 FNBP1L PKHD1L1 TFPI	1.28e-05	165	81	5	8329d780f244bc31344443b29e5a00529a016662
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	ABCA2 TTC16 TENM1 SSBP3 ANGPTL7	1.74e-05	176	81	5	5914e7635474e7cf24d446bdb1423bc0807ee9c6
ToppCell	10x5'-Lung-Lymphocytic_B_plasma-Plasmablasts\|Lung / Manually curated celltypes from each tissue	LSR BUB1 KLHL8 PKHD1L1 CSGALNACT1	1.89e-05	179	81	5	3fa75eec3e86fd1797eaa33362257df7f9b2a0bf
ToppCell	droplet-Lung-immune-endo-depleted-3m-Myeloid\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LSR AKAP5 DAB2 DAPK1 ADCY3	2.05e-05	182	81	5	3dec003bad0f3716cf8163861a9d4302a7d6df8c
ToppCell	5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ISLR2 NKX2-5 PKHD1L1 CSGALNACT1 TFPI	2.05e-05	182	81	5	53c267ee327e116dbd89d5927ed3bdf78d25ee62
ToppCell	droplet-Lung-nan-3m-Myeloid-Alveolar_Macrophage\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NPC1 LSR DAB2 DAPK1 ADCY3	2.10e-05	183	81	5	ec3c05b9ce1e0fbb720e0dea41f1e28fd3fd878f
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SYCP2 TENM1 DCC PKHD1L1 PLCE1	2.16e-05	184	81	5	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	TENM1 FNBP1L MYRFL GPC6 PLCE1	2.16e-05	184	81	5	2ba98708dfd7f1b2a661578a334684094ff453ad
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SYCP2 TENM1 DCC PKHD1L1 PLCE1	2.16e-05	184	81	5	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SYCP2 TENM1 DCC PKHD1L1 PLCE1	2.16e-05	184	81	5	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	droplet-Lung-nan-3m-Myeloid-alveolar_macrophage\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NPC1 LSR DAB2 DAPK1 ADCY3	2.16e-05	184	81	5	3261d767d5e3d9e9fbac22ad73ca14e44beed89c
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PTPN14 TENM1 GPC6 CSGALNACT1 TFPI	2.27e-05	186	81	5	f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PTPN14 TENM1 GPC6 CSGALNACT1 TFPI	2.39e-05	188	81	5	af740fa78542438fdff627ea1f74f4eee43316be
ToppCell	droplet-Heart-nan-24m-Endothelial-endocardial_endothelial_cells\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LSR PTPN14 TTC16 CSGALNACT1 TFPI	2.45e-05	189	81	5	1137583e21d874c201c20581ba1995e2bfa3de59
ToppCell	droplet-Heart-nan-24m-Endothelial-endocardial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LSR PTPN14 TTC16 CSGALNACT1 TFPI	2.52e-05	190	81	5	7068754c29f63a331e2b6c54715f3b26f37ad32b
ToppCell	facs-Lung-nan-3m-Endothelial-Lymphatic_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTPN14 LOXL2 DAB2 PKHD1L1 PLCE1	2.58e-05	191	81	5	48823a97c38263f2c6e58348214f5b62773a6368
ToppCell	facs-Lung-nan-3m-Endothelial-endothelial_cell_of_lymphatic_vessel\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTPN14 LOXL2 DAB2 PKHD1L1 PLCE1	2.58e-05	191	81	5	0eedc66e967b1837ce2c14f8c14b3c1eba868c76
ToppCell	facs-Heart-LA-3m-Endothelial-endothelial_cell_of_endocardium\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LSR PTPN14 PKHD1L1 CSGALNACT1 TFPI	2.65e-05	192	81	5	14a816ef116aa992f86edab411f043cf7d07fe04
ToppCell	facs-Heart-LA-3m-Endothelial-endocardial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LSR PTPN14 PKHD1L1 CSGALNACT1 TFPI	2.65e-05	192	81	5	847822514d747a21d5eb40e04ba9a023fd32bd65
ToppCell	COPD-Endothelial-Lymphatic\|Endothelial / Disease state, Lineage and Cell class	DAPK1 PKHD1L1 CSGALNACT1 TFPI PLCE1	2.85e-05	195	81	5	e91ce548ae7224661ee5d2f2639794a5f69798ee
ToppCell	Tracheal-NucSeq-Immune_Lymphocytic-B-B_plasma-B_plasmablast\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	AKAP5 MYL4 IMPDH2 BUB1 DCC	2.85e-05	195	81	5	c6e31038be2463f1601d52c82efa4e9facb8228f
ToppCell	droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Endothelial-endocardial_endothelial_cells\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LSR PTPN14 PKHD1L1 CSGALNACT1 TFPI	2.92e-05	196	81	5	dbf154b3d166ffd07be717dac8d8a3350ac63e16
ToppCell	Sepsis-Bac-SEP-Lymphocyte-T/NK-Treg\|Bac-SEP / Disease, condition lineage and cell class	PTPN14 TENM1 DLG3 ARMCX1 PLCE1	3.14e-05	199	81	5	e0b6136e28b813299b7ffbe37f1cf830e60cd7d8
ToppCell	LPS_anti-TNF-Hematopoietic_Erythro-Megakary-Erythro-Mega-Platelets\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	MYL4 TLN1 SPTB RABL3 ZYX	3.22e-05	200	81	5	e4be88bcef2738915f711b32c95e9c613e7edf96
ToppCell	LPS_only-Hematopoietic_Erythro-Megakary\|LPS_only / Treatment groups by lineage, cell group, cell type	MYL4 SLC22A16 SPTB BUB1 PKHD1L1	3.22e-05	200	81	5	ce8281c9556a1f64f8ca8a029110077d4ef5b35e
ToppCell	LPS_only-Hematopoietic_Erythro-Megakary-Erythro-Mega-Erythroid\|LPS_only / Treatment groups by lineage, cell group, cell type	MYL4 SLC22A16 SPTB BUB1 PKHD1L1	3.22e-05	200	81	5	83c4181c083b364f0d3a89ae7a0504781fa9fa9f
ToppCell	LPS_only-Hematopoietic_Erythro-Megakary-Erythro-Mega\|LPS_only / Treatment groups by lineage, cell group, cell type	MYL4 SLC22A16 SPTB BUB1 PKHD1L1	3.22e-05	200	81	5	f15baf287ec467664c23faa53fdea45257f7b9d0
ToppCell	Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	ISLR2 MYL4 LOXL2 DCC	5.79e-05	115	81	4	207d464c09caf9be361daa56c83cd7da5cf9ce47
ToppCell	droplet-Fat-Gat-18m-Mesenchymal-nan\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ESR1 DAPK1 ASPHD2 TFPI	9.89e-05	132	81	4	4152529611eeacf0c547e2a134d5b98c45426b13
ToppCell	LPS-IL1RA-Lymphocytic_NKT-iNKT/MAIT-Erythroid\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ABCA2 AKAP5 TENM1 B4GALNT2	1.02e-04	133	81	4	2ec3490cbf60152c3cece95eb566d749c9666517
ToppCell	frontal_cortex-Neuronal-glutamatergic_neuron-NP-L5_NP_ALM_Trhr_Nefl\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	ISLR2 MYL4 LOXL2 DCC	1.58e-04	149	81	4	558a441804dbcd5b5f39a3b1933b48976711ff15
ToppCell	primary_visual_cortex-Neuronal-glutamatergic_neuron-NP\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	ISLR2 MYL4 LOXL2 DCC	1.70e-04	152	81	4	b6a7453fbf9f898e4f222b215907c9a110baa2f6
ToppCell	facs-Spleen-nan-24m-Lymphocytic-NK_cell\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CELSR3 TENM1 ASPHD2 ZYX	1.79e-04	154	81	4	bd283c2367afb99294e7576a0c0167eb7c69ad6b
ToppCell	PND28-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_mature\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MAG LSR TKT DAPK1	1.97e-04	158	81	4	6811dc4f101dfa9a9cc13d949760d43aa522bf3b
ToppCell	TCGA-Mesothelium-Primary_Tumor-Mesothelioma-Biphasic-6\|TCGA-Mesothelium / Sample_Type by Project: Shred V9	LOXL2 BUB1 CCIN TOP3A	2.02e-04	159	81	4	85501c636cd04f15ba1be24df1ba7ac909633ce8
ToppCell	TCGA-Mesothelium-Primary_Tumor-Mesothelioma-Epitheliod-2\|TCGA-Mesothelium / Sample_Type by Project: Shred V9	SLC28A3 PKHD1L1 ADCY3 KLHL31	2.07e-04	160	81	4	d288b0a315f6adc0be4bdc89fa67bf93679a743f
ToppCell	PND07-Endothelial-Endothelial_lymphatic\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PTPN14 DAB2 PKHD1L1 PLCE1	2.12e-04	161	81	4	133b4fadb499e842c19f573f9cf09ce08c1d4813
ToppCell	PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PTPN14 DAB2 PKHD1L1 PLCE1	2.12e-04	161	81	4	9466b8658244116f8d21f2f88fb8c2d184b1bdf2
ToppCell	PBMC-Mild-Hematopoietic-Platelet-Platelet-plt_2\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	TLN1 SPTB PKHD1L1 TFPI	2.12e-04	161	81	4	bfb79277889142133ce86492a808f3083a7547e8
ToppCell	PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PTPN14 DAB2 PKHD1L1 PLCE1	2.12e-04	161	81	4	cb177ca10d848d0e25399ab5ebfcde1071fb94c2
ToppCell	PBMC-Mild-Hematopoietic-Platelet-Platelet-plt_2\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	TLN1 SPTB PKHD1L1 TFPI	2.12e-04	161	81	4	d6f4b0e4e3b2a4e6232a6de3d67b210e24f8c89d
ToppCell	facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	BUB1 TENM1 RSPH6A PKHD1L1	2.17e-04	162	81	4	bf886e22ff2a20353499004b53f25fb9e6574896
ToppCell	PND28-Immune-Immune_Myeloid-Monocytic-Macrophage-AM\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MAG LSR TKT DAPK1	2.17e-04	162	81	4	d712bc31840ad1523e3dbf884acbb428a8995001
ToppCell	PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PTPN14 DAB2 PKHD1L1 PLCE1	2.17e-04	162	81	4	96c6e94a10b124a1d25dcd705ec5aaa8609c1089
ToppCell	PND10-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PTPN14 DAB2 PKHD1L1 PLCE1	2.28e-04	164	81	4	4cfc9f92e49f86d3639e018b35b6a60dc62f494a
ToppCell	PND10-Endothelial-Endothelial_lymphatic-Lymphatic_EC\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PTPN14 DAB2 PKHD1L1 PLCE1	2.28e-04	164	81	4	7a8e5ef52a8fd2877d59ef0696af8a7af90bbed6
ToppCell	PND10-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PTPN14 DAB2 PKHD1L1 PLCE1	2.28e-04	164	81	4	5e5bd81414ea2d64f73cdef19a0a78c17bec8c18
ToppCell	PND10-Endothelial-Endothelial_lymphatic\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PTPN14 DAB2 PKHD1L1 PLCE1	2.28e-04	164	81	4	f13b8d9b7f42193f333d9a77571a1dde6bbb48d8
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_low-phase\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CD2BP2 RABL3 ZYX EXOSC4	2.38e-04	166	81	4	43f84d3cd58e93ce00c241656c4cba27604b4932
ToppCell	facs-Heart-RA-18m-Endothelial-endothelial_cell_of_endocardium\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTPN14 PKHD1L1 CSGALNACT1 TFPI	2.49e-04	168	81	4	06dc5b2d356d3a9454b10bba6f3b9ead2a0a7d46
ToppCell	facs-Heart-RA-18m-Endothelial-endocardial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTPN14 PKHD1L1 CSGALNACT1 TFPI	2.49e-04	168	81	4	1002f058a340763e3d8de0bd1f0547a903526ec6
ToppCell	droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Mesenchymal-atrial_cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYL4 GYS1 NKX2-5 KLHL31	2.61e-04	170	81	4	d99f61aa85ea3f775165cb433421e6f1cda4f96b
ToppCell	droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Mesenchymal-cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYL4 GYS1 NKX2-5 KLHL31	2.61e-04	170	81	4	615cf9639c66b3fbd984ebe3f345280005d3c38a
ToppCell	P07-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	LSR PKHD1L1 ANGPTL7 PLCE1	2.73e-04	172	81	4	9a256db817c1af1802203cc88a55d608fb328c63
ToppCell	343B-Fibroblasts-Fibroblast-H\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	MAG USP31 LOXL2 TOMM34	2.73e-04	172	81	4	eb199c279fe8a2551121db37e9556893197d33ff
ToppCell	Endothelial-B-IPF_04\|World / lung cells shred on cell class, cell subclass, sample id	PTPN14 CPXM2 LOXL2 PKHD1L1	2.73e-04	172	81	4	d4e98ff9c7cbc95457e1d71fa60f151a2f178dae
ToppCell	Bronchial_Biopsy-Endothelial-Lymphatic\|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X	ISLR2 SPTB PKHD1L1 CSGALNACT1	2.73e-04	172	81	4	c41f5a66781bbf63afce7ca5d118cc6d8e0fe0bc
ToppCell	Healthy_donor-HSPC\|Healthy_donor / disease group, cell group and cell class (v2)	MYL4 FNBP1L GPC6 TFPI	2.73e-04	172	81	4	bc7549faadfc92c683c0e26bea380458706774b5
ToppCell	343B-Fibroblasts-Fibroblast-H-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	MAG USP31 LOXL2 TOMM34	2.73e-04	172	81	4	709c6b77a7a52b873eefb6caca28a41291d384af
ToppCell	facs-Heart-LV-3m-Endothelial-endothelial_cell_of_endocardium\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTPN14 PKHD1L1 DICER1 CSGALNACT1	2.73e-04	172	81	4	f2c17c49b375b28ad47dc6cabda62f1c238023dd
ToppCell	facs-Heart-LV-3m-Endothelial-endocardial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTPN14 PKHD1L1 DICER1 CSGALNACT1	2.73e-04	172	81	4	6ab4f01098dddb789df298ddf97b3c384405ee6c
ToppCell	5'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC3_(ADGRG3+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PTPN14 PKHD1L1 KLHL31 TFPI	2.79e-04	173	81	4	7dc988fc0ba29990567bf1bcdeb3faeeee507eb1
ToppCell	LPS-IL1RA-Hematopoietic_Meg-Ery-Erythroid-Erythroid\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYL4 SLC22A16 SPTB PKHD1L1	2.91e-04	175	81	4	e4c9b3c6bde390a3892b112b673f93e118220eb9
ToppCell	LPS-IL1RA-Hematopoietic_Meg-Ery-Erythroid\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYL4 SLC22A16 SPTB PKHD1L1	2.91e-04	175	81	4	4d36da7399c62c170cb603957b35a35efb2c3fbe
ToppCell	LPS-IL1RA-Hematopoietic_Meg-Ery\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYL4 SLC22A16 SPTB PKHD1L1	2.91e-04	175	81	4	2c39c1b112e873403ad2add8595cc256bf0b97a6
ToppCell	B_cells-pDCs\|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis	NPC1 ABCA2 DAB2 FNBP1L	2.98e-04	176	81	4	ce757de9e09a225f3f96433f103f43619b0e0dda
ToppCell	droplet-Fat-SCAT-30m-Mesenchymal-nan\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAG TDRKH CPXM2 ANGPTL7	3.11e-04	178	81	4	5cf12927f0756c4d8a289fe4308d736382e6212e
ToppCell	P28-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	LSR DAB2 PKHD1L1 PLCE1	3.11e-04	178	81	4	1e05bc26591fea16e29bcfc5f538dda1dc427f05
ToppCell	5'-Adult-LymphNode-Endothelial-lymphatic_endothelial-LEC5_(CLDN11+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PTPN14 PKHD1L1 CSGALNACT1 TFPI	3.11e-04	178	81	4	4b3ea0921bc598ebb9f63780ecdf8ad4349f3666
ToppCell	PBMC-Convalescent-Hematopoietic-Platelet\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	MYL4 DAB2 FNBP1L TFPI	3.11e-04	178	81	4	f5d83ad082e31d5601890d245b9fb4f9ef6a062b
ToppCell	PBMC-Convalescent-Hematopoietic-Platelet-Platelet\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	MYL4 DAB2 FNBP1L TFPI	3.11e-04	178	81	4	a2a8fc14f492a4695e6991a357b6626145f1bf7f
ToppCell	PBMC-Convalescent-Hematopoietic-Platelet-Platelet\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MYL4 DAB2 FNBP1L TFPI	3.17e-04	179	81	4	510927794bbd21814eba75286e0801eb1fd2e8a6
ToppCell	LPS-IL1RA+antiTNF-Hematopoietic_Meg-Ery\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYL4 SLC22A16 SPTB PKHD1L1	3.17e-04	179	81	4	7329b45376a9e9a4fe34d4aa0b33af6dda0a8e3b
ToppCell	5'-Adult-LymphNode-Endothelial-lymphatic_endothelial-LEC6_(ADAMTS4+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CPXM2 LOXL2 PKHD1L1 TFPI	3.17e-04	179	81	4	9fd9b136ecbcbd4e4f0d5875ede98d8d48608afb
ToppCell	5'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC5_(CLDN11+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ISLR2 PKHD1L1 CSGALNACT1 TFPI	3.17e-04	179	81	4	40c65e8623547aeb80f9cd2366e29072467ce069
ToppCell	COVID-19-kidney-vSMC/Pericyte\|COVID-19 / Disease (COVID-19 only), tissue and cell type	SSBP3 GPC6 ADCY3 PLCE1	3.17e-04	179	81	4	111b1084f73306bdeffaaf240e7dbb4f5bf33de1
ToppCell	PBMC-Convalescent-Hematopoietic-Platelet\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MYL4 DAB2 FNBP1L TFPI	3.17e-04	179	81	4	906a5ebbbac660b6fd498ced09d0ada40a3e64af
ToppCell	LPS-IL1RA+antiTNF-Hematopoietic_Meg-Ery-Erythroid\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYL4 SLC22A16 SPTB PKHD1L1	3.17e-04	179	81	4	6e4740f99f66d3e9348fa5057cf1030454819aa8
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	TENM1 MYRFL GPC6 PLCE1	3.17e-04	179	81	4	d1365d48d1b017a7917f4f63a82ac4720c3d87df
ToppCell	LPS-IL1RA+antiTNF-Hematopoietic_Meg-Ery-Erythroid-Erythroid\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYL4 SLC22A16 SPTB PKHD1L1	3.17e-04	179	81	4	ee60ac43fb62c09967a26bbcf9306ac5ea2bdc1e
ToppCell	TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Rectal_Adenocarcinoma\|TCGA-Colorectal / Sample_Type by Project: Shred V9	TDRKH ZMIZ2 TOMM34 NSDHL	3.24e-04	180	81	4	c3d1521ac90f2e3fc31158e6e61907e05c37af39
ToppCell	PBMC-Mild-Hematopoietic-Platelet-Platelet-plt_4\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	MYL4 DAB2 FNBP1L TFPI	3.24e-04	180	81	4	1be264962fd4ed0bb59f9b8a6956c4239ca32e05
ToppCell	5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.1.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TDRKH CPXM2 LOXL2 BUB1	3.24e-04	180	81	4	40d4838a0ccb10d5e49266bc8a0037d27b75ccc2
ToppCell	PBMC-Mild-Hematopoietic-Platelet-Platelet-plt_4\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MYL4 DAB2 FNBP1L TFPI	3.24e-04	180	81	4	5568063c2518fadb638e665635061ec10d00fb6a
ToppCell	P03-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	DAB2 PKHD1L1 ANGPTL7 PLCE1	3.24e-04	180	81	4	2ccc77d769d3ffd77ab3af45e4f192785b6db79c
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	SYCP2 ABCA2 TENM1 EXOSC4	3.31e-04	181	81	4	12ff56fa2949c8d53360cdf2cacfd326e65b54aa
ToppCell	10x_3'_v2v3-Non-neoplastic-Myeloid-Mast-Mast-E\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	USP14 MYL4 SLC22A16 SPTB	3.31e-04	181	81	4	c35ca98c474e31917e0a53c092397e0d8d18b37c
ToppCell	Influenza_Severe-Platelet\|World / Disease group and Cell class	MYL4 DAB2 FNBP1L TFPI	3.31e-04	181	81	4	5cdf935a89440114a58fa2042c1daed740d91c00
ToppCell	TCGA-Head_and_Esophagus-Primary_Tumor-Head_and_Neck_Carcinoma-Squamous_Cell_Carcinoma\|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9	CD2BP2 TNKS1BP1 HMOX2 EXOSC4	3.31e-04	181	81	4	1168164994d5e2072c80d058e42aab72a0cf9867
ToppCell	PCW_13-14-Hematologic_ErythroMegGranulo\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	MYL4 SLC22A16 SPTB PKHD1L1	3.38e-04	182	81	4	e5e16abf4d3bd5a97e7c573b99f7a3d9a5add120
ToppCell	remission-Platelet\|remission / disease stage, cell group and cell class	MYL4 DAB2 FNBP1L TFPI	3.38e-04	182	81	4	65e2798aacd670cbc3a8c8e9d1a2f7768513bb70
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_A-Branch_A4_(IN)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ISLR2 ABCA2 NAT16 PCDHB1	3.38e-04	182	81	4	be32b5b8153c1053cbb55f1fccfa27c3ee97c1e1
ToppCell	PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	LOXL2 GPC6 ADCY3 PLCE1	3.45e-04	183	81	4	4060d979948e1dd7507977629a7fbdfa4ca65bb6
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	TENM1 MYRFL GPC6 PLCE1	3.45e-04	183	81	4	121791ef84e7ce377ed6f5b7953af8865e04958e
ToppCell	droplet-Heart-4Chambers-18m-Endothelial-endocardial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LSR PTPN14 PKHD1L1 TFPI	3.45e-04	183	81	4	6c4a09c02e30e1f24dde39f8cb8c5b453826ee2e
Drug	Amethopterin (R,S) [59-05-2]; Down 200; 8.8uM; PC3; HT_HG-U133A	MYL4 LOXL2 ESR1 SPTAN1 BUB1 HIF1AN TOP3A	4.40e-06	195	77	7	6654_DN
Drug	Midecamycin [35457-80-8]; Down 200; 5uM; PC3; HT_HG-U133A	TDRKH SPTAN1 TLN1 NAB1 DAB2 DLG3 ZFX	4.55e-06	196	77	7	6745_DN
Drug	Suramin sodium salt; Down 200; 10uM; PC3; HT_HG-U133A	ABCA2 PTPN14 CELSR3 KDM5A ZMIZ2 DLG3 TOP3A	4.86e-06	198	77	7	7501_DN
Drug	Carbinoxamine maleate salt [3505-38-2]; Up 200; 9.8uM; MCF7; HT_HG-U133A	TDRKH PTPN14 LOXL2 ESR1 SPTB ZFX TFPI	4.86e-06	198	77	7	6786_UP
Drug	Goserelin	NPC1 LSR SLC22A16 ESR1	1.11e-05	41	77	4	CID000047725
Drug	15d-PGJ2; Down 200; 10uM; MCF7; HT_HG-U133A_EA	ESR1 SPTAN1 DLG3 HMOX2 ARMCX1 TFPI	2.95e-05	176	77	6	1011_DN
Drug	resveratrol; Down 200; 10uM; MCF7; HT_HG-U133A_EA	ESR1 ZMIZ2 BUB1 HMOX2 DICER1 TFPI	3.04e-05	177	77	6	841_DN
Drug	Ethisterone [434-03-7]; Down 200; 12.8uM; PC3; HT_HG-U133A	ABCA2 MYL4 LOXL2 ZMIZ2 TLN1 ZYX	4.52e-05	190	77	6	4340_DN
Drug	Resveratrol [501-36-0]; Down 200; 17.6uM; MCF7; HT_HG-U133A	ESR1 BUB1 HMOX2 ADCY3 ZYX TFPI	4.80e-05	192	77	6	2865_DN
Drug	0317956-0000 [391210-11-0]; Down 200; 10uM; PC3; HT_HG-U133A	MYL4 LOXL2 ZMIZ2 TLN1 BUB1 ZYX	5.08e-05	194	77	6	4331_DN
Drug	ICI 182,780; Up 200; 1uM; PC3; HT_HG-U133A	ABCA2 MYL4 LOXL2 ESR1 HIF1AN CSGALNACT1	5.08e-05	194	77	6	1205_UP
Drug	PNU-0230031 [267429-39-0]; Down 200; 1uM; PC3; HT_HG-U133A	MYL4 ZMIZ2 TLN1 SPTB ZYX ZFX	5.08e-05	194	77	6	4291_DN
Drug	PHA-00767505E [723337-45-9]; Down 200; 10uM; MCF7; HT_HG-U133A	ABCA2 TKT ESR1 BUB1 DICER1 ZYX	5.38e-05	196	77	6	6596_DN
Drug	Thiamphenicol [15318-45-3]; Up 200; 11.2uM; HL60; HT_HG-U133A	CELSR3 ZFYVE16 ADCY3 HIF1AN CSGALNACT1 TOP3A	5.38e-05	196	77	6	1867_UP
Drug	Tinidazole [19387-91-8]; Up 200; 16.2uM; HL60; HT_HG-U133A	MYL4 LOXL2 ZMIZ2 FNBP1L ANGPTL7 HIF1AN	5.53e-05	197	77	6	2568_UP
Drug	Molindone hydrochloride [15622-65-8]; Up 200; 12.8uM; PC3; HT_HG-U133A	TDRKH SYCP2 AKAP5 ESR1 ZMIZ2 HIF1AN	5.53e-05	197	77	6	4199_UP
Drug	rosiglitazone; Down 200; 10uM; MCF7; HT_HG-U133A_EA	SYCP2 ABCA2 KDM5A ESR1 TOP3A TFPI	5.53e-05	197	77	6	1013_DN
Drug	Myosmine [532-12-7]; Up 200; 27.4uM; PC3; HT_HG-U133A	ABCA2 AKAP5 ESR1 ZMIZ2 UBR4 DCC	5.53e-05	197	77	6	3737_UP
Drug	Tiletamine hydrochloride; Up 200; 15.4uM; PC3; HT_HG-U133A	ABCA2 MYL4 CELSR3 ESR1 SPTAN1 TOP3A	5.53e-05	197	77	6	7311_UP
Drug	Gelsemine [509-15-9]; Down 200; 12.4uM; PC3; HT_HG-U133A	AKAP5 LOXL2 ESR1 SPTB BUB1 TOP3A	5.53e-05	197	77	6	4097_DN
Drug	Alfuzosin hydrochloride [81403-68-1]; Up 200; 9.4uM; MCF7; HT_HG-U133A	LOXL2 ZMIZ2 SPTB NAB1 DAB2 CSGALNACT1	5.53e-05	197	77	6	5605_UP
Drug	Mimosine [500-44-7]; Up 200; 20.2uM; MCF7; HT_HG-U133A	SYCP2 ABCA2 ESR1 SPTAN1 ZYX TOP3A	5.53e-05	197	77	6	5302_UP
Drug	Omeprazole [73590-58-6]; Up 200; 11.6uM; HL60; HT_HG-U133A	LSR ZFYVE16 ESR1 ZMIZ2 SPTB TFPI	5.69e-05	198	77	6	2467_UP
Drug	Sulfathiazole [72-14-0]; Up 200; 15.6uM; PC3; HT_HG-U133A	SYCP2 AKAP5 ZMIZ2 NAB1 BUB1 PCDHB1	5.69e-05	198	77	6	4183_UP
Drug	GSK-3 Inhibitor IX; Down 200; 0.5uM; PC3; HT_HG-U133A	ZMIZ2 SPTAN1 BUB1 ADCY3 HIF1AN TFPI	5.69e-05	198	77	6	7048_DN
Drug	Clofilium tosylate [92953-10-1]; Up 200; 7.8uM; PC3; HT_HG-U133A	KDM5A ESR1 NAB1 HMOX2 CCIN ZFX	5.69e-05	198	77	6	4492_UP
Drug	Fenspiride hydrochloride [5053-08-7]; Down 200; 13.4uM; MCF7; HT_HG-U133A	TDRKH ABCA2 MYL4 KDM5A ESR1 SPTAN1	5.69e-05	198	77	6	6001_DN
Drug	Gelsemine [509-15-9]; Down 200; 12.4uM; MCF7; HT_HG-U133A	ABCA2 MYL4 KDM5A SPTAN1 ADCY3 TFPI	5.69e-05	198	77	6	2817_DN
Drug	Hydrocotarnine hydrobromide [5985-00-2]; Up 200; 13.2uM; MCF7; HT_HG-U133A	TDRKH AKAP5 BUB1 DAPK1 DICER1 TFPI	5.85e-05	199	77	6	2765_UP
Drug	Hippeastrine hydrobromide [22352-41-6]; Up 200; 10uM; HL60; HT_HG-U133A	ZMIZ2 SPTB BUB1 DAB2 SLC28A3 ADCY3	5.85e-05	199	77	6	2187_UP
Drug	Proglumide [6620-60-6]; Down 200; 12uM; PC3; HT_HG-U133A	AKAP5 MYL4 ZMIZ2 NAB1 BUB1 TFPI	5.85e-05	199	77	6	3780_DN
Drug	prochlorperazine dimaleate salt; Down 200; 10uM; MCF7; HT_HG-U133A	ABCA2 ESR1 DLG3 HMOX2 ZYX TOP3A	6.02e-05	200	77	6	5212_DN
Drug	Naf-Az	TKT ESR1	6.74e-05	4	77	2	CID000130686
Drug	2 rF2	TENM1 DLG3 TOP3A ZFX	8.85e-05	69	77	4	CID011984575
Drug	chlorphentermine	LOXL2 SPTB PLCE1	9.14e-05	26	77	3	CID000010007
Drug	2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine	LSR IMPDH2 TKT ESR1 BUB1 DAB2 B4GALNT2 FNBP1L SSBP3	9.18e-05	545	77	9	ctd:C049584
Drug	Salisorosides Rosavin	MAG GYS1 BUB1 TOP3A	9.89e-05	71	77	4	CID003340349
Drug	5-FU	NPC1 USP14 IMPDH2 SLC22A16 ESR1 BUB1 SAMM50 DICER1 TOP3A	1.16e-04	562	77	9	CID000003385
Drug	Furazolidone-d4	NLRP12 TKT LOXL2	1.41e-04	30	77	3	CID000003435
Drug	monobut-3	MAG ESR1	1.68e-04	6	77	2	CID000130381
Drug	phenylhydrazine	LOXL2 SPTAN1 SPTB HMOX2	1.73e-04	82	77	4	CID000007516
Drug	Apralan	LSR SLC22A16 HMOX2	2.06e-04	34	77	3	CID000071428
Drug	Guanidine	SLC22A16 SPTB	3.12e-04	8	77	2	ctd:D019791
Drug	butadiene diolepoxide	TKT TFPI	4.00e-04	9	77	2	CID000108199
Drug	Spiperone [749-02-0]; Down 200; 10.2uM; PC3; HT_HG-U133A	MYL4 ESR1 BUB1 DICER1 TOP3A	4.23e-04	186	77	5	5777_DN
Drug	17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A_EA	ESR1 ZMIZ2 HMOX2 ADCY3 HIF1AN	4.23e-04	186	77	5	916_DN
Drug	Dipyridamole [58-32-2]; Up 200; 8uM; HL60; HG-U133A	MYL4 TLN1 CSGALNACT1 EXOSC4 TOP3A	4.34e-04	187	77	5	2017_UP
Drug	Forskolin, from Coleus forskohlii; Up 200; 0.5uM; PC3; HT_HG-U133A	PTPN14 MYL4 CELSR3 CD2BP2 CSGALNACT1	4.44e-04	188	77	5	7104_UP
Drug	Dicumarol [66-76-2]; Up 200; 11.8uM; MCF7; HT_HG-U133A	ABCA2 ESR1 BUB1 TOP3A ZFX	4.66e-04	190	77	5	3848_UP
Drug	AC1NV8O5	IMPDH2 SLC22A16 SLC28A3	4.76e-04	45	77	3	CID005473386
Drug	Pramoxine hydrochloride [637-58-1]; Down 200; 12.2uM; PC3; HT_HG-U133A	AKAP5 MYL4 LOXL2 ESR1 SPTB	4.78e-04	191	77	5	3811_DN
Drug	fluphenazine dihydrochloride; Down 200; 10uM; MCF7; HT_HG-U133A	CELSR3 ESR1 HMOX2 ZYX ZFX	4.78e-04	191	77	5	5234_DN
Drug	Calciferol [50-14-6]; Down 200; 10uM; PC3; HT_HG-U133A	MYL4 NAB1 BUB1 DLG3 ZFX	4.78e-04	191	77	5	6746_DN
Drug	Gabexate mesilate [56974-61-9]; Down 200; 9.6uM; HL60; HT_HG-U133A	ZFYVE16 ESR1 BUB1 DAB2 HIF1AN	4.78e-04	191	77	5	2937_DN
Drug	Megestrol acetate [595-33-5]; Up 200; 10.4uM; MCF7; HT_HG-U133A	MYL4 ESR1 DICER1 CSGALNACT1 ZFX	4.89e-04	192	77	5	5013_UP
Drug	Lasalocid sodium salt [25999-20-6]; Down 200; 6.6uM; PC3; HT_HG-U133A	ABCA2 MYL4 ESR1 ZMIZ2 HMOX2	4.89e-04	192	77	5	6639_DN
Drug	Rescinnamin [24815-24-5]; Down 200; 6.4uM; MCF7; HT_HG-U133A	MYL4 KDM5A ESR1 ZFX TFPI	4.89e-04	192	77	5	2785_DN
Drug	Berberine chloride [633-65-8]; Down 200; 10.8uM; HL60; HG-U133A	MYL4 ZFYVE16 SAMM50 DICER1 EXOSC4	4.89e-04	192	77	5	1778_DN
Drug	Noscapine [128-62-1]; Down 200; 9.6uM; MCF7; HT_HG-U133A	ABCA2 PTPN14 ESR1 ZYX ZFX	4.89e-04	192	77	5	2745_DN
Drug	H-47	AKAP5 GYS1	4.99e-04	10	77	2	CID003083866
Drug	Methylergometrine maleate [113-42-8]; Down 200; 8.8uM; PC3; HT_HG-U133A	MYL4 ZMIZ2 SPTAN1 DICER1 ZFX	5.01e-04	193	77	5	6704_DN
Drug	Methyl benzethonium chloride [25155-18-4]; Up 200; 8.6uM; MCF7; HT_HG-U133A	LOXL2 ESR1 ZMIZ2 CSGALNACT1 ZFX	5.01e-04	193	77	5	3850_UP
Drug	Ethopropazine hydrochloride [1094-08-2]; Down 200; 11.4uM; PC3; HT_HG-U133A	TDRKH MYL4 ZFYVE16 TOP3A NSDHL	5.01e-04	193	77	5	6697_DN
Drug	Isoxsuprine hydrochloride [579-56-6]; Down 200; 11.8uM; PC3; HT_HG-U133A	MYL4 ESR1 TLN1 DLG3 ZYX	5.01e-04	193	77	5	4205_DN
Drug	Skimmianine [83-95-4]; Up 200; 15.4uM; HL60; HT_HG-U133A	MAG ZMIZ2 SPTB DAB2 SLC28A3	5.13e-04	194	77	5	2504_UP
Drug	Dirithromycin [62013-04-1]; Down 200; 4.8uM; MCF7; HT_HG-U133A	TDRKH ABCA2 MYL4 ESR1 TOP3A	5.13e-04	194	77	5	2863_DN
Drug	Hexestrol [84-16-2]; Down 200; 14.8uM; PC3; HT_HG-U133A	MYL4 ZFYVE16 KDM5A ESR1 HIF1AN	5.13e-04	194	77	5	5776_DN
Drug	Piperacillin sodium salt [59703-84-3]; Down 200; 7.4uM; PC3; HT_HG-U133A	TDRKH KDM5A ZMIZ2 TLN1 HIF1AN	5.13e-04	194	77	5	4320_DN
Drug	Aconitine [302-27-2]; Up 200; 6.2uM; MCF7; HT_HG-U133A	TDRKH AKAP5 ZMIZ2 SPTB BUB1	5.13e-04	194	77	5	2776_UP
Drug	Mitoxantrone dihydrochloride [70476-82-3]; Up 200; 7.8uM; MCF7; HT_HG-U133A	MYL4 LOXL2 ESR1 HIF1AN ZYX	5.13e-04	194	77	5	5354_UP
Drug	Metoclopramide monohydrochloride [7232-21-5]; Down 200; 11.8uM; MCF7; HT_HG-U133A	ABCA2 MYL4 SPTAN1 TLN1 DICER1	5.13e-04	194	77	5	3625_DN
Drug	Androsterone [53-41-8]; Down 200; 13.8uM; MCF7; HT_HG-U133A	ESR1 BUB1 TOP3A ZFX TFPI	5.13e-04	194	77	5	2650_DN
Drug	Hesperidin [520-26-3]; Up 200; 6.6uM; MCF7; HT_HG-U133A	ABCA2 MYL4 CELSR3 ESR1 TOP3A	5.25e-04	195	77	5	5313_UP
Drug	Vitexin [3681-93-4]; Down 200; 9.2uM; MCF7; HT_HG-U133A	MYL4 KDM5A ESR1 ZYX ZFX	5.25e-04	195	77	5	2810_DN
Drug	5186324; Up 200; 2uM; MCF7; HT_HG-U133A_EA	SYCP2 PTPN14 KDM5A TLN1 TFPI	5.25e-04	195	77	5	900_UP
Drug	PF-00539758-00 [351321-34-1]; Up 200; 10uM; PC3; HT_HG-U133A	ABCA2 MYL4 CELSR3 ESR1 DICER1	5.25e-04	195	77	5	6379_UP
Drug	Harmaline hydrochloride dihydrate [6027-98-1]; Up 200; 14uM; HL60; HT_HG-U133A	ABCA2 MYL4 DAB2 DAPK1 HIF1AN	5.25e-04	195	77	5	2149_UP
Drug	Tadjakonine [11087-94-8]; Down 200; 7.4uM; MCF7; HT_HG-U133A	SYCP2 MYL4 KDM5A TLN1 ADCY3	5.25e-04	195	77	5	2820_DN
Drug	Norethynodrel [68-23-5]; Up 200; 13.4uM; PC3; HT_HG-U133A	ZFYVE16 CSGALNACT1 ZYX TOP3A TFPI	5.25e-04	195	77	5	1818_UP
Drug	Guanfacine hydrochloride [29110-48-3]; Down 200; 14.2uM; PC3; HT_HG-U133A	MYL4 ZFYVE16 DLG3 CSGALNACT1 ZFX	5.25e-04	195	77	5	4660_DN
Drug	Flupentixol dihydrochloride cis-(Z) [2413-38-9]; Up 200; 7.8uM; MCF7; HT_HG-U133A	ABCA2 KDM5A SPTAN1 NKX2-5 ARMCX1	5.25e-04	195	77	5	2643_UP
Drug	Lithocholic acid [434-13-9]; Down 200; 10.6uM; MCF7; HT_HG-U133A	LOXL2 ESR1 SPTAN1 TOP3A ZFX	5.25e-04	195	77	5	4373_DN
Drug	estradiol, USP; Up 200; 0.1uM; HL60; HT_HG-U133A	ABCA2 ESR1 NAB1 UBR4 HIF1AN	5.25e-04	195	77	5	2668_UP
Drug	Hydroquinine hydrobromide hydrate [304695-81-6]; Up 200; 9.4uM; MCF7; HT_HG-U133A	MYL4 ZMIZ2 SPTB BUB1 TOP3A	5.25e-04	195	77	5	2767_UP
Drug	rofecoxib; Up 200; 10uM; MCF7; HG-U133A	MYL4 ESR1 TLN1 HIF1AN TFPI	5.25e-04	195	77	5	166_UP
Drug	Roxarsone [121-19-7]; Up 200; 15.2uM; MCF7; HT_HG-U133A	SYCP2 MYL4 ZMIZ2 DAPK1 ZFX	5.25e-04	195	77	5	3511_UP
Drug	Apramycin [37321-09-8]; Up 200; 7.4uM; HL60; HT_HG-U133A	ESR1 ZMIZ2 DAB2 DLG3 TFPI	5.37e-04	196	77	5	2914_UP
Drug	Piribedil hydrochloride [78213-63-5]; Up 200; 12uM; HL60; HT_HG-U133A	MYL4 CELSR3 ESR1 SPTAN1 DAB2	5.37e-04	196	77	5	2951_UP
Drug	Parbendazole [14255-87-9]; Up 200; 16.2uM; MCF7; HT_HG-U133A	AKAP5 UBR4 NKX2-5 DAPK1 DICER1	5.37e-04	196	77	5	4357_UP
Drug	nordihydroguaiaretic acid; Down 200; 1uM; MCF7; HG-U133A	ESR1 SPTB DLG3 HIF1AN ZFX	5.37e-04	196	77	5	203_DN
Drug	(d,l)-Tetrahydroberberine [522-97-4]; Up 200; 11.8uM; MCF7; HT_HG-U133A	LSR ABCA2 NKX2-5 DICER1 ZYX	5.37e-04	196	77	5	2818_UP
Drug	Felodipine [72509-76-3]; Down 200; 10.4uM; MCF7; HT_HG-U133A	ABCA2 NEO1 TLN1 DLG3 ADCY3	5.37e-04	196	77	5	5294_DN
Drug	THIP Hydrochloride; Up 200; 22.6uM; HL60; HT_HG-U133A	SYCP2 ESR1 ZMIZ2 DLG3 HIF1AN	5.37e-04	196	77	5	3132_UP
Drug	Esculin Hydrate [531-75-9]; Down 200; 11.8uM; MCF7; HT_HG-U133A	TDRKH MYL4 ESR1 DICER1 ZFX	5.37e-04	196	77	5	3390_DN
Drug	Beclomethasone dipropionate [5534-09-8]; Down 200; 7.6uM; MCF7; HT_HG-U133A	TDRKH ABCA2 MYL4 ESR1 TLN1	5.37e-04	196	77	5	4403_DN
Drug	Tetramisole hydrochloride [16595-80-5]; Down 200; 16.6uM; PC3; HT_HG-U133A	MYL4 KDM5A LOXL2 TOP3A ZFX	5.37e-04	196	77	5	4587_DN
Drug	Retinoic acid [302-79-4]; Down 200; 13.4uM; PC3; HT_HG-U133A	MYL4 ESR1 DLG3 HMOX2 CSGALNACT1	5.37e-04	196	77	5	5767_DN
Drug	Colistin sulfate [1264-72-8]; Up 200; 3uM; PC3; HT_HG-U133A	SYCP2 ABCA2 NEO1 NAB1 TENM1	5.37e-04	196	77	5	4212_UP
Drug	Ethisterone [434-03-7]; Down 200; 12.8uM; PC3; HT_HG-U133A	NEO1 CELSR3 NAB1 BUB1 TFPI	5.37e-04	196	77	5	3783_DN
Drug	Diphemanil methylsulfate [62-97-5]; Down 200; 10.2uM; PC3; HT_HG-U133A	SYCP2 MYL4 ESR1 ZMIZ2 HMOX2	5.37e-04	196	77	5	4591_DN
Disease	nmrA-like family domain-containing protein 1 measurement	NLRP12 HMOX2	6.17e-05	5	74	2	EFO_0801844
Disease	multiple system atrophy	USP31 SLC28A3 PKHD1L1	1.40e-04	40	74	3	EFO_1001050
Disease	body weight	NPC1 PTPN14 ESR1 ZMIZ2 DAB2 SLC28A3 DCC SSBP3 GPC6 HIF1AN ZFX	2.93e-04	1261	74	11	EFO_0004338
Disease	cryptorchidism (biomarker_via_orthology)	KDM5A ESR1	3.36e-04	11	74	2	DOID:11383 (biomarker_via_orthology)
Disease	Oligospermia	ESR1 DICER1	4.03e-04	12	74	2	C0028960
Disease	systolic blood pressure, cigarettes per day measurement	GOLGA8S GPC6	4.75e-04	13	74	2	EFO_0006335, EFO_0006525
Disease	insulin metabolic clearance rate measurement, glucose homeostasis measurement	SLC22A16 DCC	5.54e-04	14	74	2	EFO_0006830, EFO_0006896
Disease	5-oxoproline measurement	SLC28A3 EXOSC4	7.28e-04	16	74	2	EFO_0010988
Disease	Neoplasm Invasiveness	TKT LOXL2 ESR1 TLN1	1.20e-03	184	74	4	C0027626
Disease	sudden cardiac arrest	ESR1 RSPH6A PLCE1	1.20e-03	83	74	3	EFO_0004278
Disease	ATRIAL FIBRILLATION, FAMILIAL, 1 (disorder)	MYL4 NKX2-5	1.39e-03	22	74	2	C1843687
Disease	suicidal ideation, suicide behaviour	ESR1 DCC	1.65e-03	24	74	2	EFO_0004320, EFO_0007623
Disease	Colorectal cancer	BUB1 DCC	2.09e-03	27	74	2	cv:C0346629
Disease	COLORECTAL CANCER	BUB1 DCC	2.09e-03	27	74	2	114500
Disease	Neoplasm of the large intestine	BUB1 DCC	2.09e-03	27	74	2	cv:C0009404
Disease	smoking status measurement, Cannabis use, schizophrenia	SLC28A3 DCC	2.41e-03	29	74	2	EFO_0006527, EFO_0007585, MONDO_0005090

Protein segments in the cluster

Peptide	Gene	Start	Entry
IDIQNAYLNGVGDFS	DAPK1	796	P53355
GAFAQVYEATQGDLN	BUB1	796	O43683
GQFNDGVFAYIIQEN	CCIN	291	Q13939
EQLRNGQYQASDAAG	CSGALNACT1	91	Q8TDX6
CEANKEQGGYNFQDA	B4GALNT2	141	Q8NHY0
NGSYDLANRDFCQGN	DICER1	1186	Q9UPY3
GRLNIQAGINENDFY	CPXM2	166	Q8N436
GAEAVNIAQEINGNY	ISLR2	726	Q6UXK2
TNGDYDQEQFADNQI	RABL3	126	Q5HYI8
AAADGIAAYSNYNNG	GOLGA8S	521	H3BPF8
YDDCNFSNNLVQGQG	PCDHB1	731	Q9Y5F3
GNVGNDALQYHNNTA	ANGPTL7	256	O43827
LNGDVDYFGQQFDQI	DAB2	336	P98082
GFYQCVAENEAGNAQ	DCC	396	P43146
VFAQADGSAYIEQGN	EXOSC4	31	Q9NPD3
FLYVAGGEDQNDARN	KLHL31	366	Q9H511
GVYACLAENAYGQDN	MAG	301	P20916
GAAADGIAAYSNYNN	GOLGA8T	526	H3BQL2
ENGNYFLANFIAAQN	MGAM2	1716	Q2M2H8
LQENIGNGDFSVYSA	HIF1AN	81	Q9NWT6
YFDAFIQQGGDDVQQ	NAB1	26	Q13506
AAYAGGEGLQNDFNK	GARIN4	236	Q8IYT1
QQLFNCGDGLTYNDF	IMPDH2	21	P12268
DIQKNYECANFGDQG	LOXL2	666	Q9Y4K0
EFNAAAAANAQVYGQ	ESR1	61	P03372
GHNGNAYLNTVEAFD	KLHL8	561	Q9P2G9
YLNIDAFGSDGAQVQ	NAT16	296	Q8N8M0
QQFFEAQGANGTLEN	MYRFL	11	Q96LU7
AGQEDANGCINYEAF	MYL4	176	P12829
GEGTQFYLFENVDNA	HMOX2	181	P30519
AAANNNFVNFGVGDL	NKX2-5	286	P52952
HSGFNQGYNFAEAVN	KDM5A	571	P29375
VLGGYDDQNYNNATA	NPC1	546	O15118
FDADGNYFLNRDAQI	CD2BP2	101	O95400
ADANGLQNGYVYCQS	ASPHD2	96	Q6ICH7
NAYNGNDVNFQDTSD	GPC6	476	Q9Y625
AAADGIAAYSNYNNG	GOLGA8K	526	D6RF30
AFFNILNELNDYAGQ	FNBP1L	71	Q5T0N5
DGQRDEFGFLQYANS	ABCA2	76	Q9BZC7
AENEQVGVFANDNGF	AKAP5	366	P24588
NFADFYTEESINNGG	ADCY3	931	O60266
FIEAGQFNDNLYGTS	DLG3	691	Q92796
GAAADGIAAYSNYNN	GOLGA8R	526	I6L899
HANGRVQYTFQNGED	CELSR3	991	Q9NYQ7
GAVDFYNNLENFNVD	GYS1	216	P13807
FLNAGNLCNLNYGEG	SAMM50	396	Q9Y512
DNQLNAQLAAGNPGY	LSR	146	Q86X29
VSAQDLQGNNEAYAE	LSR	221	Q86X29
FADDLGAINQEQASY	MEI4	291	A8MW99
LGQFNLYQTDQFSEG	RSPH6A	146	Q9H0K4
ELGGNFLHSFQNDNY	SSBP3	366	Q9BWW4
ADYSGQDNFLQRVGQ	PLCE1	741	Q9P212
FSLNSVNLGGNEYLN	SLC22A16	376	Q86VW1
GFYQCIAENDVGNAQ	NEO1	406	Q92859
LAGLAVQADFGDYNQ	PTPN14	141	Q15678
RGNDIFEYNSNGLLQ	TENM1	2221	Q9UKZ4
GYAVNVFDIQQGFDN	NSDHL	61	Q15738
AEGYSNVGFQNEENF	SLC28A3	11	Q9HAS3
GNNAAYSFNQNAIRE	ARMCX1	231	Q9P291
GNESFRNGQYAEASA	TOMM34	16	Q15785
FGNYGQETEEDFANQ	ZC3H6	156	P61129
NGNLDLYFVDFGDNG	TDRKH	381	Q9Y2W6
ENAIIYNNNEDFQVG	TKT	476	P29401
QGNENYAGIAARDVA	TLN1	1111	Q9Y490
ATDFQGNYFDNDRNR	SSX8P	76	Q7RTT4
FDAGLQAFQQEGIAN	SPTAN1	2021	Q13813
PVNDVYNFNLNGADD	SYCP2	866	Q9BX26
AYASQDANEQGQDLG	TNKS1BP1	896	Q9C0C2
NQRLVAQDNFGYDLA	SPTB	441	P11277
FSQANQFNYGVDNAE	PKHD1L1	56	Q86WI1
QFNYGVDNAELGNSV	PKHD1L1	61	Q86WI1
GNNALGQNYADINDQ	UBQLNL	266	Q8IYU4
GFQVDNYGTQLNAVN	TFPI	181	P10646
LAQYFGNGTELAQQE	TOP3A	631	Q13472
QQAFAEGGANKGYVQ	ZMIZ2	91	Q8NF64
AAAYGNNSDGIENRN	ZFX	361	P17010
AQQLQGQQFYSLEGA	ZYX	416	Q15942
FQLGNLAFAEADYQQ	TTC16	376	Q8NEE8
GPFDNNNQIAYVDQS	USP31	981	Q70CQ4
FAEKGEQGQYLQQDA	USP14	186	P54578
VEFGGNDLLQVYNAQ	UBR4	2301	Q5T4S7
DGNINNIYFNAEAGA	ZFYVE16	571	Q7Z3T8
AEQAGQVFNYVRDNE	NLRP12	381	P59046